methotrexate has been researched along with Kidney Diseases in 190 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 54 (28.42) | 18.7374 |
| 1990's | 36 (18.95) | 18.2507 |
| 2000's | 30 (15.79) | 29.6817 |
| 2010's | 54 (28.42) | 24.3611 |
| 2020's | 16 (8.42) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Moneim, AM; Alfwuaires, M; Alzahrani, AM; Elsawy, H; Khalil, M | 1 |
| Akin, AT; Karabulut, D; Kaymak, E; Kuloglu, N; Ozturk, E; Yakan, B | 1 |
| Aldossary, SA; Chohan, MS; Mohaini, MA; Tasleem Rasool, S | 1 |
| Baumrin, E; Berna, R; Margolis, DJ; Mitra, N; Rosenbach, M | 1 |
| Ab Hamid, S; Fu, Z; Jiang, Y; Shang, X; Wang, Z; Zhao, Q | 1 |
| Çalışkan-Ak, E; Dursun, E; Gürel-Gökmen, B; Muhan, A; Özbeyli, D; Şener, G; Sivas, GG; Tufan, E; Tunali-Akbay, T; Yılmaz-Karaoğlu, S | 1 |
| Al-Shaalan, NH; Sabry, D; Sherif, IO | 1 |
| Cai, H; Cao, X; Chen, M; Duan, M; Feng, J; Li, J; Wang, W; Yang, C; Zhang, L; Zhang, W; Zhang, Y; Zhou, D; Zhu, T; Zhuang, J | 1 |
| Abd-Elhalem, SS; Abu-El Magd, EE; El Zawawy, WK; El-Shinnawy, NA; Haggag, NZ | 1 |
| Aldhahrani, A; Alkhedaide, A; Althobaiti, F; Mohamed, WA; Nassan, MA; Soliman, MM | 1 |
| Asano, SH; Asano, Y; Hayashi, K; Matsumoto, Y; Morishita, M; Narazaki, M; Ohashi, K; Sada, KE; Wada, J; Watanabe, H; Yamamura, Y | 1 |
| Ding, N; Gao, L; Gao, LH; Wang, XB; Wang, Z; Yang, YY; Zhang, LP | 1 |
| Alarifi, S; Albasher, G; Alfarraj, S; Alkhatani, S; Almeer, R; Alqahtani, WS; Dar, AA; Fehaid, A; Moneim, AA | 1 |
| Ashizawa, M; Ban, T; Fujiwara, SI; Hatano, K; Ikeda, T; Ito, S; Kanda, Y; Kawaguchi, S; Matsuoka, S; Minakata, D; Murahashi, R; Nagayama, T; Nakano, H; Nakashima, H; Oh, I; Ohmine, K; Sato, K; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Akyol, Y; Erdemli-Kose, SB; Garli, S; Ozmen, O; Sahindokuyucu-Kocasari, F | 1 |
| Alves, AM; Bettanin, BF; Gehringer, M; Goettert, MI; Laufer, S; Majolo, F; Rocha, CM | 1 |
| Abo-Youssef, AM; Hassan, MIA; Hemeida, RAM; Osman, AT; Sharkawi, SMZ | 1 |
| Benseler, SM; Cabral, DA; Charuvanij, S; Dancey, P; Eberhard, BA; Elder, ME; Foell, D; Hersh, AO; Huber, AM; Klein-Gitelman, M; Kostik, MM; Lawson, EF; Lee, T; Li, SC; Lubieniecka, JM; Luqmani, RA; Moorthy, LN; Morishita, KA; Nielsen, SM; Ristic, G; Shenoi, S; Toth, MB; Twilt, M; Yeung, RSM | 1 |
| Ciğerci, İH; İlhan Çelik, Ö; Sakalli Çetin, E; Tetiker, H; Yılmaz, N | 1 |
| Asci, H; Aydin, B; Bas, E; Ellidag, HY; Ozmen, O; Yilmaz, N | 1 |
| Abid, S; Achour, A; Amara, I; Azzebi, A; Bacha, H; Bousabbeh, M; Guedri, Y; Rjiba-Touati, K; Salem, IB | 1 |
| Aja, PM; Azubuike-Osu, SO; Ekeleme-Egedigwe, CA; Famurewa, AC; Maduagwuna, EK; Ufebe, OG | 1 |
| Ilic, S; Jakovljevic, V; Kocic, G; Kocic, H; Stojanovic, M; Stojanovic, N; Stojiljkovic, N; Stojnev, S | 1 |
| Fernández-Codina, A; Pope, JE; Walker, KM | 1 |
| De Lavallaz, L; Musso, CG | 1 |
| Sakai, N; Wada, T | 1 |
| Severin, MJ; Torres, AM | 1 |
| de Haan, J; Oude Munnink, T; Touw, D; van der Meer, A; van Kruchten, M | 1 |
| Mamoudou, AD; Mikkelsen, TS; Schroeder, H; Tuckuviene, R; Wehner, PS | 1 |
| Chuang, H; Fanale, M; Fayad, L; Fowler, N; Hagemeister, FB; Kwak, LW; McLaughlin, P; Neelapu, S; Oki, Y; Orlowski, RZ; Ouzounian, ST; Rodriguez, MA; Romaguera, JE; Samaniego, F; Vega, F; Wang, M; Westin, JR; Younes, A | 1 |
| Aoki, H; Fujii, Y; Isogawa, M; Natsumeda, M; Ogura, R; Okada, M; Tsukamoto, Y; Yoshida, S | 1 |
| Aiyer, R; Armaghani, A; Iqbal, S; Kazory, A | 1 |
| Abdel-Raheem, IT; Khedr, NF | 1 |
| Dalia, S; Forsyth, P; Jaglal, M; Price, S; Sokol, L | 1 |
| Dabak, DO; Kocaman, N | 1 |
| Armagan, HH; Armagan, I; Bayram, D; Candan, IA; Celik, E; Uğuz, AC; Yigit, A | 1 |
| Aslaner, A; Aykaç, A; Bahar, L; Baştürk, A; Çakır, T; Durgut, H; Gül, M; Polat, C; Sabuncuoglu, MZ; Şehirli, AÖ | 1 |
| El-Gowelli, HM; El-Gowilly, SM; Helmy, MM | 1 |
| Badr, EA; Ragab, SM | 1 |
| Ahmed, W; Nabil, T; Zaki, A | 1 |
| Aksoy, N; Kocarslan, S; Oguz, E; Sezen, H; Tabur, S; Yilmaz, Z | 1 |
| Ash, S; Cohen, IJ; Issakov, J; Kollender, Y; Shkalim-Zemer, V; Toledano, H; Yaniv, I | 1 |
| Brown, V; Burton, B; Dabb, A; Holdhoff, M; Kinsman, K; Rouch, JA; Seung, AH | 1 |
| Fayad, A; González, G; Robaina Sindín, J; Smuclir Quevedo, A; Vazquez, V | 1 |
| Bozkus, F; Kurt, AH; Uremis, MM; Uremis, N | 1 |
| Öztürk, İ; Sönmez, MF; Ulusoy, HB | 1 |
| Djerada, Z; Feliu, C; Gozalo, C; Marquet, B; Millart, H; Oudart, JB | 1 |
| Mu, Q; Wan, Y; Xiao, S; Xue, M | 1 |
| Exton, LS; Kirby, B; Mohd Mustapa, MF; Smith, CH; Warren, RB; Weatherhead, SC; Yesudian, PD | 1 |
| Cabello Zurita, C; Carretero Hernández, G; González Quesada, A; Grau Pérez, M; Hernández Fernández, CP; Valerón Almazán, P; Vilar Alejo, J | 1 |
| Deray, G; Isnard-Bagnis, C; Janus, N; Karie, S; Launay-Vacher, V | 1 |
| Celtikci, B; Deng, L; Friedman, HC; James, SJ; Krupenko, NI; Krupenko, SA; Lawrance, AK; Leclerc, D; Melnyk, S; Peterson, AC; Rozen, R | 1 |
| Marrodán, L; Patiño-García, A; San-Julián, M; Sierrasesúmaga, L; Zalacaín, M | 1 |
| Salgo, R; Thaçi, D | 1 |
| Grier, HE; Janeway, KA | 1 |
| Boulinguez, S | 1 |
| Hakala, M; Immonen, K; Kautiainen, H; Vasala, M | 1 |
| Olesińska, M; Wiesik-Szewczyk, E | 1 |
| Adamson, PC; Balis, FM; Boron, M; Cole, DE; Eby, M; Fox, E; Ivy, P; Jayaprakash, N; Kim, A; Murphy, RF; O'Brien, M; Shalabi, A; Widemann, BC | 1 |
| Abdulhadi, O; Qudsi, R; Sultan, I | 1 |
| Bessell, EM; Dickinson, P; Dickinson, S; Salmon, J | 1 |
| Cai, HB; Chen, ZP; Deng, Y; He, Y; Hu, CH; Lao, XX; Li, S; Li, TJ; Qin, JY; Wang, J; Wang, LL; Yang, J; Yang, YH | 1 |
| Goto, N; Hayashi, K; Ohtsu, F; Sakakibara, J; Yano, R | 1 |
| Battistella, M; Boulinguez, S | 1 |
| Asl, NA; Asvadi, A; Asvadi, I; Hajipour, B; Khodadadi, A; Roshangar, L | 1 |
| Çakır, T; Dulundu, E; Ercan, F; Özkan, E; Şehirli, AÖ; Şener, E; Şener, G; Topaloğlu, Ü | 1 |
| Bachelez, H; Paul, C | 1 |
| Kaykhaei, MA; Mashhadi, MA; Sanadgol, H | 1 |
| Agard, C; Aslangul, E; Aumaître, O; Bienvenu, B; Boutemy, J; Broussolle, C; Comoz, F; Cordier, JF; Decaux, O; Dubois, A; Dufour, JF; Guillevin, L; Le Gallou, T; Mahr, A; Marie, I; Pagnoux, C; Pinède, L; Puéchal, X; Sève, P | 1 |
| Bhagavath, B; Carson, SA; Clark, LE; Frishman, GN; Wheeler, CA | 1 |
| Kher, A; Kher, V | 1 |
| Belavic, JM | 1 |
| Suzuki, Y | 1 |
| Aldaz, A; Aquerreta, I; Giráldez, J; Sierrasesúmaga, L | 1 |
| Arbus, GS; Bash, RO; Hansch, E; Leavey, PJ; Quigley, R; Saland, JM | 1 |
| Bode, U; Diehl, V; Elter, T; Engert, A; Fleischhack, G; Heuer, T; Josting, A; Krause, AS; Weihrauch, MR | 1 |
| Appenroth, D; Fleck, C; Hempel, L; Kentouche, K; Leder, C; Misselwitz, J; Rost, M; Zintl, F | 1 |
| Balow, JE; Langford, CA | 1 |
| Araghi, P; Bianchi, G; Ciabattoni, M; Icardi, A; Lazzarini, P; Romano, U | 1 |
| MEYERS, MC; PENNER, JA; WEINTRAUB, LR | 1 |
| BLENDIS, LM; SHRANK, AB | 1 |
| Hurkacz, M; Orzechowska-Juzwenko, K; Swierkot, J; Szechiński, J; Wiela-Hojeńska, A; Wiland, P | 1 |
| Cooper, JA; Eggert, M; Lock, BJ | 1 |
| Crews, KR; Daw, NC; Link, MP; Liu, T; Meyer, WH; Panetta, JC; Rodriguez-Galindo, C; Tan, M | 1 |
| Sugii, S | 1 |
| Roberts, JT | 1 |
| Budancamanak, M; Demirel, A; Kanter, M; Karakaya, C; Ocakci, A; Uysal, H | 1 |
| Bulbuloglu, E; Cetinkaya, A; Kantarceken, B; Kurutas, EB | 1 |
| Ayata, A; Oktem, F; Olgar, S; Ozguner, F; Uz, E; Uzare, E; Yilmaz, HR | 1 |
| Inagaki, T; Takeyama, J; Umebayashi, H | 1 |
| Harned, TM; Mascarenhas, L | 1 |
| Atasever, T; Bakkaloglu, SA; Gursel, T; Kaya, Z; Kocak, U; Oktar, SO | 1 |
| Auton, T; Borner, K; Fischer, L; Korfel, A; Martus, P; Müller, K; Schwartz, S; Thiel, E | 1 |
| Saito, E; Suwa, A; Suzuki, Y; Wakabayashi, T | 1 |
| Bourgeois, P; Deray, G; Gandjbakhch, F; Janus, N; Karie, S; Launay-Vacher, V; Mai Ba, CU; Rozenberg, S | 1 |
| Chamberlain, MC; Green, MR | 1 |
| Poster, DS; Weiss, RB | 1 |
| Powis, G | 1 |
| Rubin, P | 1 |
| Clarkson, AR; Healy, HG | 1 |
| Blandy, JP; England, HR; Oliver, RT; Risdon, RA | 1 |
| Alix, JL; Bayle, F; Cordonnier, D; Schaerer, R; Swiercz, P; Vialtel, P | 1 |
| Bloomer, WD; Garnick, MB; Goldberg, ID | 1 |
| Crowley, JJ; Deeg, HJ; Kennedy, MS; Siegel, M; Storb, R; Thomas, ED | 1 |
| Atkinson, K; Biggs, JC; Concannon, AJ; Dodds, AJ; Hayes, J; Naidoo, D; Ralston, M | 1 |
| Baum, E; Bleyer, WA; Fryer, C; Griffin, T; Lampkin, B; Lukens, J; Morgan, E; Movassaghi, N; Provisor, A; White, H | 1 |
| Birch, R; Krauss, S; Oldham, R; Omura, GA; Robert, F | 1 |
| Abelson, HT; Beardsley, GP; Fosburg, MT; Goorin, AM; Gorka, C; Link, D; Link, M | 1 |
| Alberts, DS; Borst, J; Hilgers, RD; Miles, NJ; Skipper, BE; Standefer, JC | 1 |
| Herrmann, R; Kreusser, W; Ritz, E; Tschöpe, W | 1 |
| Canellos, GP; Ervin, TJ; Kirkwood, JM; Miller, D; Pitman, SW; Weichselbaum, R | 1 |
| Gropp, C; Havemann, K | 1 |
| Gordon-Smith, EC; Harris, R; Hows, J; Palmer, S | 1 |
| Keusch, G | 1 |
| Schilsky, RL | 1 |
| Heidbreder, E; Heidland, A | 1 |
| Gabizon, AA; Gorodetsky, R; Mou, X; Vexler, AM | 1 |
| Hosaka, M; Kondoh, I; Kubota, Y; Miura, T; Noguchi, S; Shuin, T | 1 |
| Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y | 1 |
| Fiter, J; Nolla, JM; Roig Escofet, D; Valverde, J | 1 |
| Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M | 1 |
| Balla, G; Békési, A; Kovács, I; Oláh, VA; Tóth, A | 1 |
| Nakabayashi, K | 1 |
| Catsoulakos, P; Karakiulakis, G; Pispirigos, K | 1 |
| Dawes, P; Hassell, A | 1 |
| Bruno, M; Cosseddu, D; Linari, F; Manganaro, M; Pellerito, R; Ravarino, N; Torchio, B; Urbano, D | 1 |
| Brandis, M; Leititis, J; Mohrmann, M; von der Hardt, K; Zimmerhackl, RB | 1 |
| Ekman, E; Müller-Suur, R; Seideman, P | 1 |
| Kato, K; Kawai, M; Kitsuwa, S; Matsunaga, K; Okubo, T; Tani, K; Tsuzi, T | 1 |
| Abdalla, MA; Bahakim, HM; el-Badawi, MG; Fadel, RA | 1 |
| Andersson, B; Besien, K; Champlin, R; Cleary, K; Deisseroth, AB; Fischer, H; Fitzsimmons, W; Fritsche, H; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, I; Le Bherz, D; Maher, R; Mehra, R; Przepiorka, D; Woo, M | 1 |
| Arakawa, M; Hasegawa, H; Nakano, M; Nishi, S; Saito, T; Ueno, M | 1 |
| Chalmers, IM; Gough, J; Janzen, L; Jeffery, JR | 1 |
| Cachat, F; Guignard, JP | 1 |
| Swierkot, J; Szechiński, J; Wiland, P | 1 |
| Adamson, PC; Balis, FM; Montello, MJ; Murphy, RF; O'Brien, M; Sorensen, JM; Widemann, BC | 1 |
| Connaghan, DG; Devine, SM; Dix, SP; Fitzsimmons, WE; Geller, RB; Heffner, LT; Hillyer, CD; Holland, HK; Keller, J; Lin, LB; Maher, RM; Maurer, D; O'Toole, K; Rodey, GE; Wingard, JR; Winton, EF | 1 |
| Mihara, M; Moriya, Y; Takagi, N; Takeda, Y; Urakawa, K | 1 |
| Nosaka, K; Suzuki, T | 1 |
| Airoldi, M; Albanese, F; Di Costanzo, G; Fazio, M; Gariboldi, A; Mastromatteo, V; Pecchio, F | 1 |
| Brunat-Mentigny, M; Cochat, P; Dubourg, L; Hadj-Aïssa, A; Koch Nogueira, PC; Schell, M | 1 |
| Komatsuda, A; Miura, AB; Morita, K; Ohtani, H; Yamaguchi, A | 1 |
| Bacci, G; Cesari, M; Fasano, MC; Ferrari, S; Lamanna, G; Zolezzi, C | 1 |
| Chessells, JM; Hann, IM; Rees, H; Webb, DK | 1 |
| Fiter Aresté, J; Gómez Vaquero, C; Nolla Solé, JM; Roig Escofet, D; Valverde García, J | 1 |
| Kallenberg, CG; Stegeman, CA; Tervaert, JW | 1 |
| Chan, GZ; Kapoor, M | 1 |
| Lewis, V; Piatkowski, J; Rydholm, N; Sauer, M; Steiner, M | 1 |
| Blum, R; Seymour, JF; Toner, G | 1 |
| Jayne, DR | 1 |
| Chan, H; Evans, WE; Pratt, CB | 1 |
| Weismann, K | 1 |
| Chabner, BA; Coleman, CN; Johns, DG; Myers, CE | 1 |
| Hutters, L; Kristensen, LO; Weismann, K | 1 |
| Katsume, A; Mihara, M; Takeda, Y | 1 |
| Korstanje, MJ | 1 |
| Alarcón-Segovia, D; Kraus, A | 1 |
| Vogelzang, NJ | 1 |
| Christian, MC; Grem, JL; King, SA; Sorensen, JM | 1 |
| Chmurzyńska, W; Grzelakowska-Sztabert, B; Manteuffel-Cymborowska, M | 1 |
| Crom, WR; Gregory, RE; Pui, CH | 1 |
| Ellman, MH; Ginsberg, D | 1 |
| Arfeen, S; Carey, PJ; Jackson, G; Proctor, SJ; Stark, AN | 1 |
| Bell, M; Bennett, K; Gent, M; Tugwell, P | 1 |
| Deeg, HJ; McGuire, TR; Self, SG; St Pierre, BA; Sullivan, KM; Yee, GC; Zager, RA | 1 |
| Kubar, J; Milano, G; Namer, M; Schneider, M; Thyss, A | 1 |
| Dimery, IW; Legha, SS | 1 |
| Bessell, EM; Bloom, HJ; Price, P; Thompson, H | 1 |
| Abe, T; Inazawa, J; Misawa, S; Takeda, S; Takino, T; Taniwaki, M; Tsuda, S; Yashige, H; Yokota, S | 1 |
| Cangir, A; Jaffe, N; Keifer, R; Robertson, R; Wang, A | 1 |
| Crom, WR; Goren, MP; Horowitz, ME; Meyer, WH; Wright, RK | 1 |
| Furue, H | 1 |
| Appelbaum, FR; Banaji, M; Bensinger, WI; Buckner, CD; Clift, RA; Deeg, HJ; Flournoy, N; Kennedy, MS; Storb, R; Thomas, ED | 1 |
| Appelbaum, FR; Beatty, P; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Irle, C; Kennedy, M; Storb, R | 1 |
| Weinblatt, ME | 1 |
| Hennigar, GR | 1 |
| Clément, F | 1 |
| Burry, HC | 1 |
| Braun, HJ | 1 |
| Schwartz, RS; Skinner, MD | 1 |
| Mackay, IR | 1 |
| Krieglstein, J | 1 |
| Grob, PJ | 1 |
| Fetterman, GH; Holliday, MA; Rubissow, MJ | 1 |
| Bernard, J; Boiron, M; Bussel, A; Dreyfus, B; Jacquillat, C; Larrieu, MJ; Loisel, JP; Rouesse, T; Weil, M | 1 |
| Anderson, LL; Collins, GJ; Oberfield, RA; Ojima, Y; Sullivan, RD | 1 |
| Buck, AT; Taylor, DM; Threlfall, G | 1 |
| Chanes, RE; Condit, PT; Joel, W | 1 |
45 review(s) available for methotrexate and Kidney Diseases
| Article | Year |
|---|---|
Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
Topics: Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Folic Acid; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged; Pancytopenia; Skin Neoplasms; Skin Ulcer | 2022 |
How to rescue high-dose methotrexate induced nephrotoxicity and literature review about hemodiafiltration?
Topics: Antidotes; Antimetabolites, Antineoplastic; Hemodiafiltration; Humans; Kidney Diseases; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Treatment Outcome; Young Adult | 2020 |
Current jakinibs for the treatment of rheumatoid arthritis: a systematic review.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azetidines; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Kidney Diseases; Methotrexate; Piperidines; Purines; Pyrazoles; Pyrimidines; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome | 2021 |
Chronobiology in nephrology: the influence of circadian rhythms on renal handling of drugs and renal disease treatment.
Topics: Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Blood Pressure; Cardiovascular Diseases; Chronopharmacokinetics; Circadian Rhythm; Diuretics; Furosemide; Humans; Kidney; Kidney Diseases; Methotrexate; Pharmaceutical Preparations; Water-Electrolyte Balance | 2018 |
Treatment of moderate-to-severe plaque psoriasis.
Topics: Abnormalities, Drug-Induced; Alefacept; Antibodies, Monoclonal; Clinical Trials as Topic; Contraindications; Cyclosporine; Etanercept; Female; Fumarates; Hematologic Diseases; Humans; Hypertension; Immunoglobulin G; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Photochemotherapy; Pregnancy; Pregnancy Complications; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retinoids; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2009 |
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects.
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Hearing Loss; Heart Diseases; Humans; Ifosfamide; Infertility; Kidney Diseases; Methotrexate; Neoplasms, Second Primary; Neurotoxicity Syndromes; Osteosarcoma; Survivors | 2010 |
[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
Topics: Biological Products; Contraindications; Cyclosporine; Drug Administration Routes; Drug Monitoring; Female; Folic Acid; Humans; Immunosuppressive Agents; Kidney Diseases; Latent Tuberculosis; Liver Cirrhosis; Medical History Taking; Methotrexate; Pregnancy; Pregnancy Complications; Psoriasis; Pulmonary Fibrosis; Recurrence; Tumor Necrosis Factor-alpha; Vaccination | 2010 |
[Management of patients with systemic sclerosis].
Topics: Bone Marrow Transplantation; Cyclophosphamide; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Kidney Diseases; Lung Diseases, Interstitial; Methotrexate; Prognosis; Quality of Life; Raynaud Disease; Scleroderma, Systemic; Stem Cell Transplantation; Treatment Outcome | 2010 |
Glucarpidase (Voraxaze) for methotrexate toxicity.
Topics: Animals; gamma-Glutamyl Hydrolase; Humans; Kidney Diseases; Metabolic Clearance Rate; Methotrexate | 2012 |
Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature.
Topics: Adult; Aged; Constriction, Pathologic; Cystostomy; Follow-Up Studies; Genital Diseases, Male; Glucocorticoids; Granuloma, Plasma Cell; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nephrectomy; Prednisone; Prostatectomy; Recurrence; Retrospective Studies; Skin Ulcer; Stents; Transurethral Resection of Prostate; Ureteral Diseases; Young Adult | 2012 |
Immunotherapy in renal diseases.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Plasmapheresis; Prognosis; Recurrence; Rituximab | 2012 |
New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Models, Animal; Humans; Kidney; Kidney Diseases; Methotrexate; Mice; Mycophenolic Acid; Rituximab; Vasculitis | 2003 |
[Kidney involvement in rheumatoid arthritis].
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Autopsy; Biopsy; Cyclosporine; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Methotrexate; Nephritis, Interstitial; Penicillamine; Time Factors | 2003 |
Infiltrative lung disease due to noncytotoxic agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Aspirin; Humans; Hydrochlorothiazide; Iatrogenic Disease; Kidney Diseases; Lung Diseases; Lung Diseases, Interstitial; Methotrexate; Narcotics; Organogold Compounds; Syndrome | 2004 |
[Adverse effects of DMARDs in treatment of rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Sodium Thiomalate; Hematologic Diseases; Humans; Isoxazoles; Kidney Diseases; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Reproduction; Sulfasalazine | 2005 |
Chemotherapy for metastatic bladder cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Comorbidity; Doxorubicin; Humans; Kidney Diseases; Methotrexate; Neoplasm Metastasis; Phenotype; Prognosis; Randomized Controlled Trials as Topic; Survival; Urinary Bladder Neoplasms; Vinblastine | 2005 |
[Adverse effects of conventional DMARDs and biologic DMARDs].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Cysteine; Drug Eruptions; Drug Hypersensitivity; Hematologic Diseases; Humans; Immune System Diseases; Infliximab; Isoxazoles; Kidney Diseases; Leflunomide; Lung Diseases; Methotrexate | 2007 |
The renal toxicity of cancer chemotherapeutic agents.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Azacitidine; Cisplatin; Cyclophosphamide; Dacarbazine; Humans; Kidney Diseases; Methotrexate; Mitomycins; Naphthacenes; Nitrosourea Compounds; Plicamycin; Streptozocin; Thioguanine | 1982 |
Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs.
Topics: Antineoplastic Agents; Aspartic Acid; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Fluorouracil; Gallium; Humans; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Methotrexate; Phosphonoacetic Acid; Protein Binding; Tegafur | 1982 |
The Franz Buschke lecture: late effects of chemotherapy and radiation therapy: a new hypothesis.
Topics: Antineoplastic Agents; Bleomycin; Bone Marrow Diseases; Brain Diseases; Cardiomyopathies; Carmustine; Cisplatin; Doxorubicin; Gastrointestinal Diseases; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Methotrexate; Neoplasms; Radiotherapy | 1984 |
Urinary tract toxic effects of cancer therapy.
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Cystitis; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Methotrexate; Nephritis; Radiation Injuries; Radiation Tolerance; Radiotherapy; Semustine; Streptozocin; Ureteral Obstruction | 1984 |
Nephrological complications of cancer therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Humans; Ifosfamide; Kidney; Kidney Diseases; Methotrexate; Mitomycin; Mitomycins; Nitrosourea Compounds; Vinblastine; Vincristine | 1982 |
[Toxic lesions caused by cytostatic drugs].
Topics: Alopecia; Antineoplastic Agents; Arrhythmias, Cardiac; Blood Platelets; Blood Transfusion; Bone Marrow; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Diarrhea; Digestive System; Doxorubicin; Female; Hair; Humans; Kidney Diseases; Lung; Male; Methotrexate; Methotrimeprazine; Mutation; Pericarditis; Pregnancy; Pulmonary Fibrosis; Thrombocytopenia; Vincristine | 1980 |
[Kidney disorders caused by antineoplastic agents].
Topics: Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Kidney Diseases; Methotrexate; Mitomycin; Nimustine | 1994 |
Serious problems with methotrexate?
Topics: Arthritis, Rheumatoid; Humans; Kidney Diseases; Liver Cirrhosis; Lung Diseases; Methotrexate | 1994 |
[Renal damage in rheumatoid arthritis].
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclosporine; Female; Glomerulonephritis; Gold; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Methotrexate; Middle Aged; Penicillamine; Vasculitis | 1994 |
Cytostatics--induced tubular toxicity.
Topics: Antineoplastic Agents; Cisplatin; Humans; Ifosfamide; Kidney Diseases; Kidney Tubules; Methotrexate; Risk Factors | 1993 |
[Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature].
Topics: Age Factors; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Contraindications; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged; Pancytopenia; Pneumonia, Pneumocystis; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
[Drug-induced renal disorders in patients with rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Humans; Kidney Diseases; Methotrexate; ortho-Aminobenzoates | 1996 |
[The kidney in children under chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Ifosfamide; Kidney; Kidney Diseases; Kidney Function Tests; Methotrexate; Mitomycin; Semustine | 1996 |
[Nephrotoxicity of antineoplastic drugs].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cisplatin; Cyclophosphamide; Humans; Ifosfamide; Kidney Diseases; Methotrexate; Streptozocin | 1997 |
Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antilymphocyte Serum; Cyclophosphamide; Guanidines; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Isoxazoles; Kidney Diseases; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisone; Remission Induction; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha; Vasculitis | 2001 |
Malignancy and renal disease.
Topics: Acute Kidney Injury; Antineoplastic Agents; Bone Marrow Transplantation; Cisplatin; Cyclosporine; Hepatorenal Syndrome; Humans; Kidney Diseases; Methotrexate; Multiple Myeloma; Neoplasms; Renal Replacement Therapy | 2001 |
Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis.
Topics: Azathioprine; Cyclophosphamide; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Microcirculation; Secondary Prevention; Treatment Outcome; Vasculitis | 2002 |
The clinical pharmacology of antineoplastic agents (first of two parts).
Topics: Animals; Antineoplastic Agents; Asparaginase; Binding Sites; Biological Transport; Chemical and Drug Induced Liver Injury; Depression, Chemical; DNA, Neoplasm; Drug Interactions; Drug Resistance; Floxuridine; Fluorouracil; Folic Acid Antagonists; Humans; Kidney Diseases; Liver; Lung Diseases; Methotrexate; Mice; Neoplasms; Tetrahydrofolate Dehydrogenase | 1975 |
Nephrotoxicity from chemotherapy: prevention and management.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Gallium; Humans; Ifosfamide; Kidney Diseases; Methotrexate; Mitomycin; Neoplasms; Nitrosourea Compounds; Plicamycin | 1991 |
Clinical use of thymidine as a rescue agent from methotrexate toxicity.
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Kidney; Kidney Diseases; Male; Meta-Analysis as Topic; Methotrexate; Middle Aged; Thymidine | 1991 |
Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines.
Topics: Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Humans; Kidney Diseases; Methotrexate; Societies, Medical; United States | 1989 |
[Late effects of cancer chemotherapy].
Topics: Antineoplastic Agents; Bone and Bones; Chemical and Drug Induced Liver Injury; Cisplatin; Female; Fibrosis; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver Cirrhosis; Male; Methotrexate; Neoplasm Metastasis; Neoplasms; Pituitary Gland; Pregnancy; Testis | 1987 |
Toxicity of low dose methotrexate in rheumatoid arthritis.
Topics: Abnormalities, Drug-Induced; Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infertility, Female; Infertility, Male; Kidney Diseases; Lung Diseases; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Random Allocation; Risk; Skin Diseases | 1985 |
[Clinical picture, diagnostics and therapy of amyloidoses].
Topics: Adrenal Gland Diseases; Amyloidosis; Biopsy; Chloroquine; Chronic Disease; Gastrointestinal Diseases; Humans; Infections; Kidney Diseases; Liver Diseases; Methotrexate; Neoplasms; Pancreatic Diseases; Prognosis; Splenic Diseases | 1972 |
Methotrexate in the treatment of psoriasis.
Topics: Abnormalities, Drug-Induced; Bone Marrow; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Kidney Diseases; Leucovorin; Liver; Methotrexate; Pregnancy; Psoriasis; Skin | 1972 |
Immunosuppressive therapy of immunoinflammatory diseases.
Topics: Abnormalities, Multiple; Abortion, Spontaneous; Collagen Diseases; Cyclophosphamide; Female; Gastrointestinal Diseases; Hematologic Diseases; Immune System Diseases; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Leukopenia; Liver Function Tests; Lymphoma; Mercaptopurine; Methotrexate; Nervous System Diseases; Pregnancy | 1974 |
[Plasma protein binding of drugs].
Topics: Adult; Age Factors; Bilirubin; Blood Protein Disorders; Chemical Phenomena; Chemistry; Chromatography, Gel; Coumarins; Glucocorticoids; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Kidney; Kidney Diseases; Methotrexate; Pharmaceutical Preparations; Protein Binding; Serum Albumin; Sulfaphenazole; Ultracentrifugation; Water | 1969 |
[Current status of immunosuppressive therapy in non-neoplastic disorders].
Topics: Arthritis; Autoimmune Diseases; Azathioprine; Bone Marrow; Bone Marrow Diseases; Chemical Phenomena; Chemistry; Cyclophosphamide; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Kidney Diseases; Methotrexate; Prognosis; Skin Diseases | 1970 |
24 trial(s) available for methotrexate and Kidney Diseases
| Article | Year |
|---|---|
Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Child; Child, Preschool; Combined Modality Therapy; Cross-Over Studies; Female; Fluid Therapy; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Kidney Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Time Factors; Tissue Distribution; Young Adult | 2014 |
Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Hematologic Diseases; Humans; Kidney Diseases; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Risk; Rituximab; Thrombosis; Vincristine; Young Adult | 2013 |
Pharmacodynamics of high-dose methotrexate in pediatric patients.
Topics: Adolescent; Adult; Algorithms; Antimetabolites, Antineoplastic; Area Under Curve; Child; Child, Preschool; Female; Fluorescence Polarization Immunoassay; Hematologic Diseases; Humans; Kidney Diseases; Linear Models; Logistic Models; Male; Methotrexate; Neoplasms; Predictive Value of Tests | 2002 |
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
Topics: Adolescent; Adult; Age Factors; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Ifosfamide; Kidney Diseases; Male; Methotrexate; Osteosarcoma; Treatment Outcome | 2004 |
Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Kidney Diseases; Kidney Function Tests; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Turkey; Vincristine | 2007 |
Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Female; gamma-Glutamyl Hydrolase; Humans; Immunoassay; Kidney Diseases; Male; Methotrexate; Middle Aged; Neoplasms; Renal Insufficiency; Risk Factors; Time Factors; Treatment Outcome | 2007 |
Renal dysfunction during and after high-dose methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Case-Control Studies; Central Nervous System Neoplasms; Creatinine; Dose-Response Relationship, Drug; Female; gamma-Glutamyl Hydrolase; Humans; Kidney; Kidney Diseases; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Child; Creatinine; Cyclosporins; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Methotrexate; Random Allocation | 1983 |
Treatment of patients with metastatic osteogenic sarcoma: a report from the Children's Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Kidney Diseases; Leucovorin; Male; Methotrexate; Neoplasm Metastasis; Neutropenia; Osteosarcoma; Thrombocytopenia; Time Factors; Vincristine | 1984 |
Randomized phase III comparison of three doxorubicin-based chemotherapy regimens in advanced non-small cell lung cancer: a Southeastern Cancer Study Group trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Kidney Diseases; Lung Neoplasms; Methotrexate; Middle Aged; Myeloproliferative Disorders; Nausea; Prognosis; Random Allocation; Time Factors | 1984 |
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney Diseases; Leucovorin; Liver; Liver Neoplasms; Methotrexate; Neoplasms; Nervous System Diseases; Ovarian Neoplasms; Remission Induction; Spectrophotometry, Atomic; Tumor Cells, Cultured; Vinblastine | 1995 |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome | 1995 |
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
Topics: Actuarial Analysis; Administration, Oral; Adult; Anemia, Refractory, with Excess of Blasts; Bone Marrow Transplantation; Creatinine; Disease-Free Survival; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Diseases; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Salvage Therapy; Survival Analysis; Tacrolimus; Transplantation Conditioning | 1996 |
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Infections; Kidney Diseases; Life Tables; Liver Diseases; Male; Methotrexate; Middle Aged; Pilot Projects; Safety; Survival Analysis; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 1997 |
A novel antifolate, MX-68, inhibits the development of autoimmune disease in MRL/lpr mice.
Topics: 2-Aminoadipic Acid; Administration, Oral; Animals; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Blood Urea Nitrogen; Cell Division; Cholesterol; DNA, Single-Stranded; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Kidney Diseases; Lupus Nephritis; Lymph Nodes; Methotrexate; Mice; Mice, Inbred MRL lpr; Picrates; Proteinuria; Specific Pathogen-Free Organisms; Spleen | 1997 |
Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Creatinine; Female; Humans; Ifosfamide; Kidney Diseases; Kidney Function Tests; Male; Methotrexate; Osteosarcoma | 1998 |
Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Bone Neoplasms; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Kidney; Kidney Diseases; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Prospective Studies | 1999 |
Recovery from toxicity associated with high-dose methotrexate: prognostic factors.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Dehydration; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Infant; Kidney Diseases; Kidney Function Tests; Leucovorin; Liver Diseases; Liver Function Tests; Male; Methotrexate; Neoplasms; Pleural Effusion; Prognosis; Time Factors; Vomiting | 1977 |
Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.
Topics: Bone Marrow Transplantation; Creatinine; Cyclosporins; Drug Administration Schedule; Graft vs Host Disease; Humans; Kidney Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Randomized Controlled Trials as Topic | 1989 |
Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney Diseases; Male; Mannitol; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Random Allocation; Sodium Chloride | 1986 |
Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Bacterial Infections; Bone Marrow Transplantation; Cyclosporins; Depression; Graft vs Host Disease; Humans; Hypertension; Kidney Diseases; Length of Stay; Leukemia; Liver Diseases; Methotrexate; Middle Aged; Mycoses; Pulmonary Fibrosis; Random Allocation | 1985 |
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.
Topics: Adult; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Kidney Diseases; Leukemia; Liver Diseases; Methotrexate; Middle Aged; Recurrence; Vascular Diseases; Whole-Body Irradiation | 1985 |
Toxicity of low dose methotrexate in rheumatoid arthritis.
Topics: Abnormalities, Drug-Induced; Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infertility, Female; Infertility, Male; Kidney Diseases; Lung Diseases; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Random Allocation; Risk; Skin Diseases | 1985 |
Pharmacologic studies of methotrexate in cancer patients with uropathy.
Topics: Colonic Neoplasms; Humans; Injections, Intravenous; Kidney Diseases; Kidney Function Tests; Methotrexate; Neoplasms; Pelvic Neoplasms; Tritium | 1970 |
122 other study(ies) available for methotrexate and Kidney Diseases
| Article | Year |
|---|---|
Nephroprotective effect of naringin in methotrexate induced renal toxicity in male rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Caspase 3; Disease Models, Animal; Flavanones; Inflammation Mediators; Interleukin-6; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Rats; Tumor Necrosis Factor-alpha | 2021 |
Evaluation by different mechanisms of the protective effects of vitamin B12 on methotrexate nephrotoxicity.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Catalase; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; In Situ Nick-End Labeling; Interleukin-6; Kidney Diseases; Male; Malondialdehyde; Methotrexate; Rats; Rats, Wistar; Superoxide Dismutase; Vitamin B 12; Vitamin B Complex | 2022 |
Capsaicin ameliorate the nephrotoxicity induced by methotrexate.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Capsaicin; Disease Models, Animal; Inflammation Mediators; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Rats, Sprague-Dawley | 2021 |
Evaluating the effect of methotrexate on the rate of renal fibrosis by elastography and fibrosis-related gene expression.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Elasticity Imaging Techniques; Fibrosis; Gene Expression; Humans; Kidney Diseases; Liver Cirrhosis; Methotrexate; Transforming Growth Factor beta | 2022 |
Whey protein concentrate ameliorates the methotrexate-induced liver and kidney damage.
Topics: Animals; Antioxidants; Glutathione; Kidney; Kidney Diseases; Liver; Methotrexate; Oxidative Stress; Rats; Rats, Sprague-Dawley; Whey Proteins | 2023 |
Topics: Animals; Ginkgo biloba; Humans; Kidney; Kidney Diseases; Male; Methotrexate; Phosphatidylinositol 3-Kinases; Plant Extracts; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA, Long Noncoding; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Intravenous methotrexate at a dose of 1 g/m
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cerebrospinal Fluid; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Kidney Diseases; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mucositis; Neoplasm Invasiveness; Prednisone; Proportional Hazards Models; Prospective Studies; Recurrence; Rituximab; Vincristine | 2020 |
Application of either nano fibrillated cellulose methotrexate or nano silicon dioxide methotrexate composites against renal fibrosis in leukemia rat model.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers; Cellulose; Disease Models, Animal; Drug Carriers; Fibrosis; Kidney Diseases; Leukemia; Male; Methotrexate; Nanofibers; Nanoparticles; Rats; Silicon Dioxide | 2020 |
The ameliorative impacts of Moringa oleifera leaf extract against oxidative stress and methotrexate-induced hepato-renal dysfunction.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; Inflammation Mediators; Kidney; Kidney Diseases; Liver; Male; Methotrexate; Mice; Moringa oleifera; Oxidative Stress; Plant Extracts; Plant Leaves; Signal Transduction | 2020 |
Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Japan; Kidney; Kidney Diseases; Male; Methotrexate; Middle Aged; Regression Analysis; Retrospective Studies; Surveys and Questionnaires | 2020 |
The protective role of luteolin against the methotrexate-induced hepato-renal toxicity via its antioxidative, anti-inflammatory, and anti-apoptotic effects in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidant Response Elements; Apoptosis; Chemical and Drug Induced Liver Injury; Inflammation; Kidney; Kidney Diseases; Luteolin; Male; Methotrexate; Oxidative Stress; Protective Agents; Rats | 2021 |
Risk factors for high-dose methotrexate-induced nephrotoxicity.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Uric Acid; Young Adult | 2021 |
Apigenin alleviates methotrexate-induced liver and kidney injury in mice.
Topics: Animals; Antimetabolites, Antineoplastic; Apigenin; Chemical and Drug Induced Liver Injury; Kidney Diseases; Male; Methotrexate; Mice; Molecular Structure; Oxidative Stress | 2021 |
Empagliflozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats.
Topics: Acetylcysteine; Animals; Benzhydryl Compounds; Glucosides; Hesperidin; Inflammation; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Protective Agents; Rats; Signal Transduction | 2021 |
Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Diseases; Male; Methotrexate; Mycophenolic Acid; Prospective Studies; Recurrence; Registries; Remission Induction; Retrospective Studies; Rituximab | 2017 |
[Methotrexate-Induced Nephrotoxicity in Rats: Protective Effect of Mistletoe (Viscum album L.) Extract].
Topics: Animals; DNA Damage; Female; Kidney Diseases; Methotrexate; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Viscum album | 2017 |
The impact of gallic acid on the methotrexate-induced kidney damage in rats.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Blood Urea Nitrogen; Creatinine; Gallic Acid; Humans; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Uric Acid | 2017 |
Recombinant human erythropoietin prevents etoposide- and methotrexate-induced toxicity in kidney and liver tissues via the regulation of oxidative damage and genotoxicity in Wistar rats.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Catalase; Chemical and Drug Induced Liver Injury; DNA Damage; Erythropoietin; Etoposide; Glutathione; Kidney; Kidney Diseases; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methotrexate; Protective Agents; Rats, Wistar; Recombinant Proteins | 2018 |
Antioxidant and anti-inflammatory effects of virgin coconut oil supplementation abrogate acute chemotherapy oxidative nephrotoxicity induced by anticancer drug methotrexate in rats.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Coconut Oil; Dietary Supplements; Glutathione; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Methotrexate; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2017 |
The Encapsulation of Lycopene in Nanoliposomes Enhances Its Protective Potential in Methotrexate-Induced Kidney Injury Model.
Topics: Animals; Carotenoids; Kidney; Kidney Diseases; Lycopene; Male; Methotrexate; Rats; Rats, Wistar | 2018 |
Treatment Algorithms for Systemic Sclerosis According to Experts.
Topics: Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Calcium Channels; Cyclophosphamide; Endothelin Receptor Antagonists; Glucocorticoids; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Kidney Diseases; Lung Diseases, Interstitial; Methotrexate; Mycophenolic Acid; Phosphodiesterase 5 Inhibitors; Prostaglandins; Raynaud Disease; Rituximab; Scleroderma, Systemic | 2018 |
[Immunosuppressants-induced kidney injury].
Topics: Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Ribonucleosides; TOR Serine-Threonine Kinases | 2016 |
Time course effects of methotrexate on renal handling of water and electrolytes in rats. Role of aquaporin-2 and Na-K-2Cl-cotransporter.
Topics: Animals; Aquaporin 2; Biomarkers; Chlorides; Electrolytes; Kidney Diseases; Kidney Tubules; Male; Methotrexate; Potassium; Rats, Wistar; Renal Reabsorption; Sodium; Solute Carrier Family 12, Member 1; Time Factors; Urodynamics; Water | 2019 |
Reversible Impaired Methotrexate Clearance After Platinum-Based Chemotherapy for Osteosarcoma.
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Cisplatin; Doxorubicin; Drug Interactions; Female; Humans; Kidney Diseases; Leucovorin; Methotrexate; Morphine; Mucositis; Osteosarcoma | 2019 |
Advantages of dose-dense methotrexate protocol for primary central nervous system lymphoma: comparison of two different protocols at a single institution.
Topics: Academies and Institutes; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Female; Hematologic Diseases; Hospitals, University; Humans; Kaplan-Meier Estimate; Kidney Diseases; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Procarbazine; Remission Induction; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2013 |
Methotrexate nephrotoxicity: Novel treatment, new approach.
Topics: Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; gamma-Glutamyl Hydrolase; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged | 2013 |
Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
Topics: Acetates; Animals; Antimetabolites, Antineoplastic; Cyclopropanes; Glutathione; Kidney; Kidney Diseases; Leukotriene Antagonists; Male; Malondialdehyde; Methotrexate; NF-kappa B; Peroxidase; Protective Agents; Quinolines; Rats; Rats, Wistar; Sulfides; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2014 |
What is the optimal dose of high-dose methotrexate in the initial treatment of primary central nervous system lymphoma?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Treatment Outcome; Young Adult | 2015 |
Effects of silymarin on methotrexate-induced nephrotoxicity in rats.
Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Disease Models, Animal; Kidney Diseases; Male; Methotrexate; Rats; Rats, Sprague-Dawley; Silymarin | 2015 |
Effects of pentoxifylline and alpha lipoic acid on methotrexate-induced damage in liver and kidney of rats.
Topics: Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Kidney Diseases; Male; Methotrexate; Pentoxifylline; Rats; Rats, Sprague-Dawley; Thioctic Acid | 2015 |
The effect of alpha lipoic acid on rat kidneys in methotrexate induced oxidative injury.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Female; Glutathione; Interleukin-1beta; Kidney; Kidney Diseases; Male; Malondialdehyde; Methotrexate; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Thioctic Acid; Tumor Necrosis Factor-alpha | 2015 |
Pioglitazone ameliorates methotrexate-induced renal endothelial dysfunction via amending detrimental changes in some antioxidant parameters, systemic cytokines and Fas production.
Topics: Animals; Antioxidants; Cytokines; fas Receptor; Glutathione; Kidney; Kidney Diseases; Male; Malondialdehyde; Methotrexate; Oxidative Stress; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones | 2015 |
Evaluation of serum and urine fetuin-A levels in children with acute lymphoblastic leukemia during and after high-dose methotrexate therapy: Relation to toxicity.
Topics: Adolescent; alpha-2-HS-Glycoprotein; Child; Child, Preschool; Female; Humans; Infant; Kidney Diseases; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2016 |
Prevention of methotrexate-induced nephrotoxicity by concomitant administration of garlic aqueous extract in rat.
Topics: Adenosine Deaminase; Animals; Calcium; Catalase; Creatinine; Disease Models, Animal; Garlic; Glutathione; Kidney Diseases; Male; Malondialdehyde; Methotrexate; Nitric Oxide; Phosphorus; Plant Extracts; Potassium; Rats; Rats, Wistar; Sodium; Urea | 2015 |
Effects of Lycopene Alone or Combined with Melatonin on Methotrexate-Induced Nephrotoxicity in Rats.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antioxidants; Carotenoids; Drug Therapy, Combination; Glutathione; Interleukin-1beta; Kidney Diseases; Lycopene; Male; Melatonin; Methotrexate; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2015 |
Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Substitution; Etoposide; Female; Follow-Up Studies; Hearing Loss; Humans; Ifosfamide; Kidney Diseases; Leucovorin; Male; Methotrexate; Osteosarcoma; Pilot Projects; Stroke Volume; Survival Rate; Treatment Outcome; Young Adult | 2015 |
Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
Topics: Antacids; Citrates; Female; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Sodium Acetate; Sodium Bicarbonate; Sodium Citrate; Urine | 2017 |
[Clinical practice guideline for ANCA-associated vasculitis with renal involvement].
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Azathioprine; Child; Clinical Trials as Topic; Cyclophosphamide; Evidence-Based Medicine; Glucocorticoids; Humans; Induction Chemotherapy; Kidney Diseases; Maintenance Chemotherapy; Methotrexate; Organ Dysfunction Scores; Plasmapheresis; Recurrence; Severity of Illness Index | 2015 |
The protective role of G protein-coupled estrogen receptor 1 (GPER-1) on methotrexate-induced nephrotoxicity in human renal epithelium cells.
Topics: Antimetabolites, Antineoplastic; Cells, Cultured; Epithelial Cells; Estradiol; Humans; Kidney Diseases; Kidney Tubules, Proximal; Methotrexate; Nitriles; Phenols; Propionates; Protective Agents; Pyrazoles; Receptors, Estrogen | 2016 |
Protective effect of propolis on methotrexate-induced kidney injury in the rat.
Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Cytoprotection; Heat-Shock Proteins; Kidney Diseases; Methotrexate; Oxidative Stress; Propolis; Rats; Rats, Wistar; Treatment Outcome | 2016 |
Analytical interference in the therapeutic drug monitoring of methotrexate.
Topics: Adolescent; Bone Neoplasms; Contraindications; Cross Reactions; Drug Monitoring; Drug Substitution; Fluorescence Polarization Immunoassay; Humans; Kidney Diseases; Male; Methotrexate; Osteosarcoma | 2016 |
Spontaneous renal hemorrhage caused by invasive mole: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Etoposide; Female; Hemorrhage; Humans; Hydatidiform Mole, Invasive; Kidney Diseases; Leucovorin; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 2016 |
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
Topics: Adult; Alcohol Drinking; Biological Products; Bone Marrow Diseases; Checklist; Chemical and Drug Induced Liver Injury; Chickenpox; Child; Counseling; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Approval; Drug Interactions; Drug Monitoring; Drug Overdose; Evidence-Based Medicine; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Intraoperative Complications; Kidney Diseases; Lung Diseases; Methotrexate; Nausea; Neoplasms; Off-Label Use; Patient Education as Topic; Patient Safety; Pregnancy; Pregnancy Complications; Retinoids; Skin Diseases; Tuberculosis; Ultraviolet Rays; Vaccination | 2016 |
Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Dermatologic Agents; Female; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies; Treatment Outcome | 2017 |
[Chemotherapy and renal toxicity].
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Kidney; Kidney Diseases; Lomustine; Methotrexate; Organoplatinum Compounds; Oxaliplatin | 2008 |
Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice.
Topics: Animals; Cells, Cultured; Female; Gene Expression; Homocysteine; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Polymorphism, Single Nucleotide | 2008 |
Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Carrier Proteins; Case-Control Studies; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Folate Receptors, GPI-Anchored; Folic Acid; Gastrointestinal Diseases; Genotype; Hematologic Diseases; Humans; Kidney Diseases; Male; Methotrexate; Osteosarcoma; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Cell Surface; RNA, Messenger; Tetrahydrofolate Dehydrogenase | 2009 |
More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Antirheumatic Agents; Blood Sedimentation; Creatinine; Female; Finland; Humans; Incidence; Kidney; Kidney Diseases; Kidney Transplantation; Male; Methotrexate; Middle Aged; Prevalence; Proteinuria; Rectum; Rheumatic Diseases; Subcutaneous Fat, Abdominal; Young Adult | 2010 |
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; gamma-Glutamyl Hydrolase; Humans; Infant; Kidney Diseases; Leucovorin; Male; Methotrexate; Middle Aged; Thymidine | 2010 |
Low-dose carboxypeptidase-G2 for methotrexate toxicity in a child.
Topics: Adolescent; gamma-Glutamyl Hydrolase; Humans; Kidney Diseases; Male; Methotrexate; Osteosarcoma | 2010 |
Increasing age at diagnosis and worsening renal function in patients with primary central nervous system lymphoma.
Topics: Aged; Aging; Central Nervous System Neoplasms; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Diseases; Longitudinal Studies; Lymphoma; Male; Methotrexate; Middle Aged; Retrospective Studies; Statistics, Nonparametric | 2011 |
[The dissemination of CMV in urine of different group from Guangxi and the relationship between CMV infection and renal disease].
Topics: China; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Ethnicity; Female; Humans; Infant, Newborn; Kidney Diseases; Kidney Transplantation; Methotrexate; Polymerase Chain Reaction; Pregnancy | 2010 |
[Risk factors and subjective symptoms of drug-induced leucopenia].
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Autoimmune Diseases; Case-Control Studies; Child; Databases, Factual; Female; Humans; Kidney Diseases; Leukopenia; Logistic Models; Male; Methimazole; Methotrexate; Middle Aged; Risk Factors; Ritodrine; Sex Factors; Ticlopidine; Young Adult | 2011 |
[Update on psoriasis at the Dermatology Day conference, Paris 2010].
Topics: Comorbidity; Creatinine; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Liver Cirrhosis; Methotrexate; Psoriasis; Risk Factors; Severity of Illness Index | 2011 |
Protective effect of pentoxyfilline in renal toxicity after methotrexate administration.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Blood Urea Nitrogen; Creatinine; Cytoprotection; Disease Models, Animal; Glutathione Peroxidase; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Methotrexate; Pentoxifylline; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Caffeic acid phenethyl ester (CAPE) prevents methotrexate-induced hepatorenal oxidative injury in rats.
Topics: Animals; Antimetabolites, Antineoplastic; Caffeic Acids; Chemical and Drug Induced Liver Injury; Female; Glutathione; Interleukin-1beta; Kidney Diseases; Male; Malondialdehyde; Methotrexate; Oxidative Stress; Peroxidase; Phenylethyl Alcohol; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Tumor Necrosis Factor-alpha | 2011 |
[Choice of therapy based on clinical setting].
Topics: Age Factors; Comorbidity; Contraindications; Cyclosporine; Decision Making; Dermatologic Agents; Female; Hepatic Insufficiency; Humans; Kidney Diseases; Latent Tuberculosis; Mental Disorders; Methotrexate; Pregnancy; Psoriasis; Risk Factors; Skin Neoplasms | 2011 |
Low prevalence of high-dose methotrexate nephropathy in patients with malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Child; Child, Preschool; Creatinine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Young Adult | 2012 |
Role of routine monitoring of liver and renal function during treatment of ectopic pregnancies with single-dose methotrexate protocol.
Topics: Abortifacient Agents, Nonsteroidal; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Diagnostic Tests, Routine; Dose-Response Relationship, Drug; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Liver; Liver Function Tests; Methotrexate; Middle Aged; Monitoring, Physiologic; Predictive Value of Tests; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Young Adult | 2012 |
Voraxaze treats toxic methotrexate levels.
Topics: Drug Approval; Drug Interactions; gamma-Glutamyl Hydrolase; Humans; Kidney Diseases; Methotrexate; Nurse Practitioners; Practice Guidelines as Topic | 2012 |
[Anti-rheumatic drugs].
Topics: Antirheumatic Agents; Cysteine; Hematologic Diseases; Humans; Hypersensitivity; Infections; Isoxazoles; Kidney Diseases; Leflunomide; Liver Neoplasms; Lung Diseases; Methotrexate | 2012 |
Effective removal of methotrexate by high-flux hemodialysis.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Female; Fluorescence Polarization Immunoassay; gamma-Glutamyl Hydrolase; Half-Life; Humans; Hypokalemia; Hypophosphatemia; Infusions, Intravenous; Kidney Diseases; Male; Methotrexate; Osteosarcoma; Renal Dialysis; Rhabdomyosarcoma | 2002 |
Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.
Topics: Adult; Antidotes; Female; gamma-Glutamyl Hydrolase; Humans; Kidney Diseases; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasms; Osteosarcoma; Treatment Outcome | 2002 |
Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Child; Child, Preschool; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Tubules; Male; Methotrexate; Prospective Studies; Proteinuria | 2003 |
ACUTE URIC ACID NEPHROPATHY IN LEUKEMIA. REPORT OF A CASE TREATED WITH PERITONEAL DIALYSIS.
Topics: Acute Kidney Injury; Adolescent; Blood; Dialysis; Humans; Kidney Diseases; Leukemia; Mercaptopurine; Metabolism; Methotrexate; Peritoneal Dialysis; Renal Dialysis; Renal Insufficiency; Toxicology; Uric Acid; Urine | 1964 |
FOLIC-ACID ANTAGONISTS IN TREATMENT OF PSORIASIS.
Topics: Drug Therapy; Duodenal Ulcer; Folic Acid Antagonists; Kidney Diseases; Kidney Tubules; Leukopenia; Melena; Methotrexate; Mouth Diseases; Necrosis; Pathology; Psoriasis; Toxicology | 1965 |
[Renal tubular dysfunction in patients with rheumatoid arthritis starting with low dose of methotrexate].
Topics: Acetylglucosaminidase; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Kidney Tubules; Male; Methotrexate; Middle Aged | 2003 |
Protective effects of thymoquinone and methotrexate on the renal injury in collagen-induced arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Benzoquinones; Kidney Diseases; Male; Methotrexate; Protective Agents; Rats; Rats, Wistar | 2006 |
The effects of N-acetylcysteine on methotrexate-induced oxidative renal damage in rats.
Topics: Acetylcysteine; Animals; Antioxidants; Glutathione; Humans; Kidney; Kidney Diseases; Methotrexate; Oxidants; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar | 2007 |
Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester.
Topics: Animals; Caffeic Acids; Catalase; Free Radical Scavengers; Glutathione Peroxidase; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Methotrexate; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Superoxide Dismutase | 2006 |
Renal involvement in a patient with juvenile idiopathic arthritis presenting after treatment for Hodgkin lymphoma.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Hematuria; Hodgkin Disease; Humans; Kidney Diseases; Methotrexate; Methylprednisolone; Prednisolone; Proteinuria; Sulfasalazine; Treatment Outcome | 2007 |
Severe methotrexate toxicity precipitated by intravenous radiographic contrast.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Marrow; Child; Contrast Media; Female; Humans; Kidney Diseases; Male; Methotrexate; Mucositis; Tomography, X-Ray Computed | 2007 |
Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study.
Topics: Adult; Age Distribution; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Function Tests; Male; Methotrexate; Middle Aged; Prevalence; Prospective Studies; Proteinuria; Risk Assessment; Sex Distribution; Urinalysis | 2008 |
Renal complications of cytotoxic therapy.
Topics: Animals; Antineoplastic Agents; Asparaginase; Cisplatin; Cyclophosphamide; Cytarabine; Dogs; Fluorouracil; Humans; Kidney Diseases; Methotrexate; Mitomycins; Neoplasms; Nitrosourea Compounds; Plicamycin; Procarbazine; Streptozocin; Syndrome | 1983 |
Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma.
Topics: Aged; Carcinoma, Transitional Cell; Drug Eruptions; Humans; Kidney Diseases; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1984 |
[Nephrotoxicity of antitumor chemotherapy].
Topics: Antineoplastic Agents; Cisplatin; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Humans; Kidney Diseases; Methotrexate; Mitomycin; Mitomycins; Nitrosourea Compounds; Plicamycin | 1984 |
Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes.
Topics: Acute Kidney Injury; Anemia, Aplastic; Bilirubin; Bone Marrow Transplantation; Creatinine; Cyclosporins; Humans; Kidney Diseases; Leukemia; Methotrexate; Purpura, Thrombotic Thrombocytopenic; Syndrome; Time Factors; Uremia | 1983 |
Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
Topics: Adolescent; Adult; Child; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Inulin; Kidney Diseases; Kinetics; Leucovorin; Methotrexate; Neoplasms; Thymidine | 1983 |
Phase II and pharmacokinetic study of high-dose methotrexate in the treatment of advanced gynecologic malignancy. A Southwest Oncology Group Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemical and Drug Induced Liver Injury; Drug Evaluation; Female; Genital Neoplasms, Female; Hematologic Diseases; Humans; Kidney Diseases; Kinetics; Leucovorin; Methotrexate; Middle Aged; Nausea; Time Factors | 1984 |
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Gastrointestinal Diseases; Head and Neck Neoplasms; Humans; Kidney Diseases; Leucovorin; Male; Methotrexate; Middle Aged; Myeloproliferative Disorders; Prognosis | 1981 |
Immunosuppression with cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anaemia: preliminary studies.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclosporins; Female; Graft Survival; Graft vs Host Reaction; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Transplantation, Homologous | 1981 |
[Drug-induced kidney disorders].
Topics: Aminoglycosides; Anti-Bacterial Agents; Glomerulonephritis; Humans; Ischemia; Kidney; Kidney Diseases; Methotrexate; Nephritis, Interstitial | 1982 |
Renal and metabolic toxicities of cancer chemotherapy.
Topics: Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Electrolytes; Glomerular Filtration Rate; Humans; Kidney Diseases; Methotrexate; Neoplasms; Nitrosourea Compounds; Nucleic Acids; Uric Acid | 1982 |
[Toxic nephropathies (author's transl)].
Topics: Analgesics; Drug Hypersensitivity; Ethylene Glycols; Glomerulonephritis; Humans; Hypercalcemia; Kidney Concentrating Ability; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubular Necrosis, Acute; Methicillin; Methotrexate; Nephritis, Interstitial; Oxalates | 1980 |
Schedule-intensified M-VAC chemotherapy for advanced urothelial cancer with recombinant human granulocyte colony stimulating factor (rhG-CSF).
Topics: Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Urologic Neoplasms; Vinblastine | 1994 |
[Methotrexate treatment of amyloidosis secondary to rheumatoid arthritis].
Topics: Amyloidosis; Arthritis, Rheumatoid; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors | 1995 |
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminopeptidases; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD13 Antigens; Cisplatin; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Proteinuria; Urinary Bladder Neoplasms; Vincristine | 1993 |
Urinary N-acetyl-beta-D-glucosaminidase activity in leukaemic children during high-dose methotrexate therapy.
Topics: Acetylglucosaminidase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Burkitt Lymphoma; Child; Creatinine; Diuresis; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Kidney Tubules, Proximal; Leucovorin; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Evaluation of kidney and liver subacute toxicity of antitumor agents using serum biochemical parameters in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Azasteroids; Blood Glucose; Chemical and Drug Induced Liver Injury; Chlorambucil; Cholesterol; Cisplatin; Epirubicin; gamma-Glutamyltransferase; Kidney; Kidney Diseases; Liver Diseases; Male; Methotrexate; Nitrogen; Nitrogen Mustard Compounds; Potassium; Rats; Rats, Wistar; Sodium; Weight Loss | 1993 |
Renal effects of low dose methotrexate in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Chromium Radioisotopes; Dose-Response Relationship, Drug; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Technetium Tc 99m Mertiatide | 1993 |
Nephrotoxicity of low-dose methotrexate in guinea pigs: an ultrastructural study.
Topics: Animals; Antidotes; Antimetabolites, Antineoplastic; Blood Cell Count; Bone Marrow; Guinea Pigs; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Leucovorin; Methotrexate; Microscopy, Electron | 1996 |
Response to methotrexate in a patient with idiopathic eosinophilic fasciitis, morphea, IgM hypergammaglobulinemia, and renal involvement.
Topics: Adult; Eosinophilia; Fasciitis; Humans; Hypergammaglobulinemia; Immunoglobulin M; Kidney Diseases; Male; Methotrexate; Scleroderma, Localized | 1995 |
N-acetyl-beta-D-glucosaminidase urinary excretion as an early indicator of kidney dysfunction in rheumatoid arthritis patients on low-dose methotrexate treatment.
Topics: Acetylglucosaminidase; Adult; Aged; Albuminuria; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Creatinine; Female; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Uric Acid | 1997 |
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Topics: Adolescent; Adult; Antidotes; Antimetabolites, Antineoplastic; Carboxypeptidases; Child; Child, Preschool; Female; Humans; Infant; Kidney; Kidney Diseases; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Thymidine | 1997 |
[Urinary lysozyme, beta-2-microglobulin, and alpha-glucosidase during cisplatin therapy].
Topics: alpha-Glucosidases; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Betamethasone; Biomarkers; Bleomycin; Cisplatin; Diuresis; Fluid Therapy; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Methotrexate; Mouth Neoplasms; Muramidase; Neoplasm Proteins; Predictive Value of Tests; Sensitivity and Specificity; Vincristine | 1983 |
Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate.
Topics: Amyloidosis; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Methotrexate; Middle Aged; Nephrotic Syndrome; Prednisolone; Remission Induction | 1998 |
Are glomerular filtration rate estimations necessary before high dose methotrexate?
Topics: Antimetabolites, Antineoplastic; Child; Cost-Benefit Analysis; Female; Glomerular Filtration Rate; Hematologic Neoplasms; Humans; Kidney Diseases; Male; Methotrexate | 1999 |
[Secondary amyloidosis in rheumatoid arthritis. A clinical study of 29 patients].
Topics: Adult; Aged; Amyloidosis; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Kidney Diseases; Male; Methotrexate; Middle Aged; Prognosis | 1999 |
Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia.
Topics: Adolescent; Antimetabolites, Antineoplastic; Humans; Kidney Diseases; Leucovorin; Male; Methotrexate; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioisotope Renography | 2002 |
Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment.
Topics: Adult; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Methotrexate; Osteosarcoma; Vancomycin | 2002 |
Methotrexate therapy for psoriasis in elderly patients with impaired renal function.
Topics: Age Factors; Aged; Humans; Kidney Diseases; Methotrexate; Psoriasis | 1977 |
Renal function and the rate of disappearance of methotrexate from serum.
Topics: Adult; Aged; Aging; Creatinine; Female; Half-Life; Humans; Injections, Intravenous; Kidney; Kidney Diseases; Kidney Function Tests; Kinetics; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged | 1975 |
Effect of methotrexate treatment on the onset of autoimmune kidney disease in lupus mice.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Female; Kidney Diseases; Lupus Vulgaris; Male; Methotrexate; Mice; Mice, Inbred Strains | 1992 |
How to improve the risk-benefit ratio of cyclosporin therapy for psoriasis.
Topics: Cyclosporine; Drug Therapy, Combination; Humans; Kidney Diseases; Methotrexate; Psoriasis; PUVA Therapy; Retinoids | 1992 |
Low dose MTX and NSAID induced "mild" renal insufficiency and severe neutropenia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Methotrexate; Middle Aged; Neutropenia | 1991 |
Ornithine decarboxylase induction in mouse kidney as indicator of renal damage. Differential nephrotoxic effect of anticancer antifolate drugs.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers; Enzyme Induction; Female; Folic Acid; Folic Acid Antagonists; Indomethacin; Kidney; Kidney Diseases; Methotrexate; Mice; Organ Size; Ornithine Decarboxylase; Quinazolines | 1991 |
Raised plasma methotrexate concentrations following intrathecal administration in children with renal dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Female; Half-Life; Humans; Injections, Spinal; Kidney Diseases; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
Low-dose methotrexate and severe neutropenia in patients undergoing renal dialysis.
Topics: Agranulocytosis; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Methotrexate; Neutropenia; Renal Dialysis | 1990 |
Severe renal toxicity due to intermediate-dose methotrexate.
Topics: Adult; Aged; Back Pain; Bicarbonates; Fluid Therapy; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mouthwashes; Sodium; Sodium Bicarbonate; Stomatitis | 1989 |
Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen.
Topics: Adolescent; Adult; Aged; Drug Interactions; Drug Therapy, Combination; Female; Humans; Ketoprofen; Kidney Diseases; Lymphoma; Male; Methotrexate; Middle Aged; Osteosarcoma; Phenylpropionates; Retrospective Studies; Time Factors | 1986 |
Renal impairment following the combined use of high-dose methotrexate and procarbazine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Humans; Kidney Diseases; Medulloblastoma; Methotrexate; Procarbazine; Vincristine | 1988 |
The use of diamox in the sequential methotrexate-5-fluorouracil therapy of advanced gastrointestinal cancer.
Topics: Acetazolamide; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Gastrointestinal Neoplasms; Humans; Kidney Diseases; Methotrexate | 1988 |
Renal toxicity with cumulative doses of cis-diamminedichloroplatinum-II in pediatric patients with osteosarcoma. Effect on creatinine clearance and methotrexate excretion.
Topics: Child; Cisplatin; Creatine; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Methotrexate; Osteosarcoma | 1987 |
Urinary N-acetyl-beta-D-glucosaminidase and serum creatinine concentrations predict impaired excretion of methotrexate.
Topics: Acetylglucosaminidase; Adolescent; Adult; Child; Cisplatin; Creatinine; Half-Life; Hexosaminidases; Humans; Kidney Diseases; Methotrexate; Osteosarcoma | 1987 |
Iatrogenic drug toxicity.
Topics: Acetaminophen; Age Factors; Amphotericin B; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Hemolysis; Humans; Isoniazid; Kidney Diseases; Methotrexate; Pharmaceutical Preparations; Probability; Time Factors | 1985 |
[The treatment of disseminated lupus erythematosus. So-called immunosuppressive drugs].
Topics: Adolescent; Antibodies, Antinuclear; Autoantibodies; Betamethasone; Female; Hepatitis; Humans; Immune Tolerance; Immunosuppressive Agents; Kidney Diseases; Lupus Erythematosus, Systemic; Melphalan; Methotrexate; Neutrophils; Prednisone; Splenectomy | 1970 |
Monilial septicaemia in acute leukaemia. Successful treatment in a case complicated by acute uric acid nephropathy.
Topics: Acetazolamide; Adolescent; Amphotericin B; Candidiasis; Humans; Infectious Mononucleosis; Kidney Diseases; Leukemia; Male; Mercaptopurine; Methotrexate; Nystatin; Penicillins; Peripheral Nervous System Diseases; Prednisone; Rolitetracycline; Sepsis; Uric Acid | 1966 |
Autoimmune disease.
Topics: Adolescent; Antibodies, Antinuclear; Antigen-Antibody Reactions; Autoantibodies; Autoimmune Diseases; Azathioprine; Child; Complement System Proteins; Corticosterone; Cyclophosphamide; Female; Fluorescent Antibody Technique; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immunosuppressive Agents; Kidney Diseases; Lupus Erythematosus, Systemic; Lymphoid Tissue; Male; Methotrexate | 1969 |
Proximal tubular hypertrophy in a case of acute leukemia of childhood: a study by microdissection.
Topics: Acute Disease; Child, Preschool; Humans; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Prednisone | 1970 |
Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases.
Topics: Acute Disease; Asparaginase; Asparagine; Blood Coagulation Disorders; Cells, Cultured; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Daunorubicin; Humans; Kidney Diseases; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Liver Function Tests; Methotrexate; Prednisone; Valine; Vincristine | 1970 |
Chemically-induced renal hypertrophy in the rat.
Topics: Animals; DNA; Folic Acid; Hypertrophy; Kidney; Kidney Diseases; Male; Methotrexate; Organ Size; Pyridines; Pyrimidines; Rats; RNA; Triamterene; Ureteral Obstruction; Xanthopterin | 1968 |
Renal toxicity of methotrexate.
Topics: Aged; Aminohippuric Acids; Blood Urea Nitrogen; Carcinoma, Squamous Cell; Ear Neoplasms; Female; Humans; Inulin; Kidney; Kidney Diseases; Leiomyosarcoma; Leukocyte Count; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Tongue Neoplasms | 1969 |